학술논문
LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S1161-S1161
Subject
Language
ISSN
0923-7534